By staff of The Canadian Press
Posted on August 2, 2022 at 4:36 pm
Smaller Font Decrease the font size of the article
-A
Larger Font Increase the font size of the article
A+
The local organizer of an international AIDS conference in Montreal says the event has helped highlight the tremendous progress that has been made in HIV research and treatment technology.
Dr Jean-Pierre Routy, local chair of the conference, says the breakthrough presented was research showing that a single injection of a long-acting antiretroviral drug can prevent people from acquiring HIV infection for two months , replacing daily pills.
Despite visa issues that prevented hundreds of delegates from attending, Routy says people from 172 countries were present at the event, which ends on Tuesday.
Read more: Canada announces $17.9 million at Montreal AIDS conference to expand HIV testing
But Tinashe Rufurwadzo, director of programs, management and governance at Y+ Global, an international organization of HIV-positive youth, says the AIDS 2022 conference was bittersweet.
Trending stories
-
Montreal mother apologizes for police intervention at children’s lemonade stand
-
The dark side of winning the lottery: The lucky ticket can cause new problems, say past winners
Story continues below ad
He says attendees were able to have meetings that wouldn’t have been possible otherwise, such as with government officials and pharmaceutical executives, but many voices were missing because of visa issues.
More than 9,000 people were expected to attend in person, with another 2,000 people registered to participate online.
1:32 “One pandemic cannot overshadow another,” says Health Minister on HIV/AIDS “One pandemic cannot overshadow another,” says Health Minister on HIV/AIDS
© 2022 The Canadian Press